I initiated a position in GSK recently. The stock is attractively priced, partly due to currency effects, and the weak pound will continue to be a tailwind for the business. The company returned to growth, but it needs to gain more momentum. …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
LONDON (Reuters) - GlaxoSmithKline (GSK.L) said on Thursday its Chief Executive ... 164 percent on average for the European pharmaceuticals sector. Recently, GSK stock has done better, largely on the back of its HIV drug business, …
Dear Mr. Berko: My broker has recommended that I invest $20,000 and buy 500 shares of GlaxoSmithKline, a world-class drug company. The dividend is $2.48 and that yields a very attractive 5.9 percent He thinks Glaxo's problems are over …
Claim your 2-week free trial to StreetInsider Premium here. GlaxoSmithKline plc (NYSE: GSK) and Innoviva, Inc. …
Grasso's kids own EFA, EFG, EWJ, IJR, SPY. Grasso's firm is long stock AMD, COTY, CTL, CUBA, DIA, F, GE, GLD, GSK, HPQ, IAU, IBM, ICE, LEN, MAT, …
The stock has the highest rural exposure and offers attractive valuations. The recent underperformance has been due to margin concerns. Volume growth has picked …
Glaxosmithkline Pharmaceuticals (Q4 ... Several imminent triggers and stock ignoring crude spike gains. Morgan Stanley On GAIL Maintained ‘Overweight’ …